Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Imagineer Co.,Ltd., First Half Ordinary Profit Increases by 22%
4644 Imagineer Co.,Ltd. 【J-GAAP】
Earnings ReportImagineer Co.,Ltd. <4644> [TSE-S] announced its financial results after the market closed on October 31st (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) increased by 22.1% from the same period last year, reaching 503 million yen. The progress rate against the 670 million yen full-year plan was 75.1%, also surpassing the five-year average of 48.5%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to drop by 31.6% from the same period last year to 167 million yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit decreased to 203 million yen, a 20.1% decrease compared to the same period last year. However, the operating profit margin drastically improved from 6.5% in the same period last year to 15.3%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2022 | 2,824 | 180 | 594 | 393 | 41.0 | 63.7 | Oct 31, 2022 | J-GAAP |
Apr - Sep, 2023 | 2,765 | 137 | 412 | 283 | 29.5 | 62.8 | Oct 31, 2023 | J-GAAP |
Apr - Sep, 2024 | 2,809 | 299 | 503 | 332 | 34.6 | 75.1 | Oct 31, 2024 | J-GAAP |
YoY | +1.6% | +118.2% | +22.1% | +17.3% | +17.1% |
First Half Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2024 Guidance | ー | ー | ー | ー | - | 22.50 | May 15, 2024 | J-GAAP |
Apr - Sep, 2024 Results | 2,809 | 299 | 503 | 332 | 34.6 | 22.50 | Oct 31, 2024 | J-GAAP |
Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 3,195 | 208 | 244 | 133 | 13.8 | 25 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 3,391 | 151 | 167 | 128 | 13.3 | 22.50 | Oct 31, 2024 | J-GAAP |
YoY | +6.1% | -27.4% | -31.6% | -3.8% | -4.0% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 6,640 | 596 | 932 | 610 | 63.6 | 32 | May 15, 2023 | J-GAAP |
Mar, 2024 | 5,960 | 345 | 656 | 416 | 43.3 | 45 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 6,200 | 450 | 670 | 460 | 47.8 | 45 | May 15, 2024 | J-GAAP |
YoY | +4.0% | +30.4% | +2.1% | +10.6% | +10.4% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Sep, 2023 | 1,380 | 90 | 254 | 176 | 18.4 | 6.5 | Oct 31, 2023 | J-GAAP |
Oct - Dec, 2023 | 1,468 | 56 | -8 | -15 | -1.6 | 3.8 | Jan 31, 2024 | J-GAAP |
Jan - Mar, 2024 | 1,727 | 152 | 252 | 148 | 15.4 | 8.8 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 1,391 | 82 | 300 | 196 | 20.4 | 5.9 | Jul 31, 2024 | J-GAAP |
Jul - Sep, 2024 | 1,418 | 217 | 203 | 136 | 14.2 | 15.3 | Oct 31, 2024 | J-GAAP |
YoY | +2.8% | +141.1% | -20.1% | -22.7% | -22.9% |
Related Articles
CROSS CAT CO.,LTD., First Half Ordinary Profit Revised Upward by 24%, Highest in Two Terms
SymBio Pharmaceuticals Limited, January-September (Third Quarter Cumulative) Net Income Loss Widens, July-September Net Income Loss Widens
SANSO ELECTRIC CO.,LTD., First Half Ordinary Profit Turns to Loss, July-September Ordinary Profit Turns to Loss
HOCHIKI CORPORATION, First Half Ordinary Profit Revised Upward to an Unexpected 56% Increase, Adds to Record High Profit
Nomura Micro Science Co.,Ltd., First Half Ordinary Profit Revised Downward by 97%
CHIMNEY CO., LTD., The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 10% Decrease
FUJI ELECTRIC CO., LTD., The Current Fiscal Year Ordinary Profit Revised Upward by 2%, Adds to Record High Profit Forecast
Kyowa Kirin Co., Ltd., July-September (3Q) Net Income Decreases by 43%
EIKEN CHEMICAL CO.,LTD., The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 8% Decrease
OKUMA Corporation, The Current Fiscal Year Ordinary Profit Revised Downward by 20%